Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 10Other 2Lymphoid 2Classical hematology 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Myelodysplastic Syndromes 100Leukemia, Myeloid, Acute 93Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Myeloproliferative Disorders 71Multiple Myeloma 65Lymphoma, Non-Hodgkin 62Leukemia 62Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Leukemia, Lymphocytic, Chronic, B-Cell 58Hodgkin Disease 58Primary Myelofibrosis 52Lymphoma, Mantle-Cell 45Lymphoma, Large B-Cell, Diffuse 42Burkitt Lymphoma 42Lymphoma, Follicular 41Leukemia, Myeloid, Chronic-Phase 40Lymphoma, B-Cell, Marginal Zone 39Lymphoma 39Lymphoma, Large-Cell, Immunoblastic 38Congenital Abnormalities 37Lymphoma, T-Cell, Cutaneous 35Leukemia, Myeloid, Accelerated Phase 35Sezary Syndrome 32Mycosis Fungoides 32Leukemia, Myelomonocytic, Chronic 32Blast Crisis 32Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 28Pdgfra-Associated Chronic Eosinophilic Leukemia 27Leukemia, Neutrophilic, Chronic 27Neoplasms, Plasma Cell 26

Interventions

Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Renal Insufficiency × Myeloid × Clear all
NCT02360111 2019-07-24

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
3 enrolled 6 charts
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡